Nanda Gamad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nanda Gamad has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Ashish Bhalla
Department of Internal Medicine, PGIMER, Chandigarh, India
2 shared publications- Nusrat Shafiq
Post Graduate Institute of Medical Education and Research
2 shared publications Ritin Mohindra
Department of Internal Medicine, PGIMER, Chandigarh, India
2 shared publicationsAishwarya Anand
Department of Pharmacology, PGIMER, Chandigarh, India
1 shared publication- Ajay Singh
Department of Anesthesia & Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
1 shared publication Akshay Vijayakumar
Department of Otolaryngology(Head & Neck Surgery), PGIMER, Chandigarh, India
1 shared publication
Latest Publications
- Open Access
- 30 September 2024
- Published by Society of Antimicrobial Stewardship PractIces (SASPI)
- Vol. 2 (3) , 22-28
Implementation of a Clinical Pharmacology-Centric Antimicrobial Stewardship Initiative within COVID-19 Intensive Care Units at a Leading Tertiary Care Referral Center in India
Background: The importance of antimicrobial stewardship during the COVID-19 pandemic remains underreported. Methods: We prospectively audited antimicrobial use in COVID-19 ICUs of a tertiary care center from April 2021 to June 2021 during the delta wave of COVID-19 in India. Prospective audits and feedback (PAF) were conducted concurrently during case discussions on all days during this period. A summary of feedback, including empiric antibiotic rationality, de-escalation, etc., was mailed to all the treating physicians every day. Results: 161 out of 183 patients (87.97%) were empirically prescribed antibiotics in COVID ICUs, with an average of three antibiotics per patient. The most commonly prescribed empiric antibiotic was piperacillin-tazobactam, followed by ceftriaxone and colistin. De-escalation was suggested in 45.2% of prescriptions, which were followed in 36.5% but delayed in around 16% of suggestions. The presence of multiple comorbidities with intubation and/or shock was the most common reason for initiating and continuing empirical antibiotics. Around 29.8% of the patients on antibiotics developed MDR infections, and Acinetobacter baumannii was the most common organism isolated, with an average length of stay of 20 (19.6 days). Conclusion: Antimicrobial stewardship can play an essential role in minimizing the use of unnecessary antimicrobials in COVID-19 patients.
- 30 September 2024
- Published by Society of Antimicrobial Stewardship PractIces (SASPI)
- Vol. 2 (3) , 22-28
Open AccessImplementation of a Clinical Pharmacology-Centric Antimicrobial Stewardship Initiative within COVID-19 Intensive Care Units at a Leading Tertiary Care Referral Center in India
Background: The importance of antimicrobial stewardship during the COVID-19 pandemic remains underreported. Methods: We prospectively audited antimicrobial use in COVID-19 ICUs of a tertiary care center from April 2021 to June 2021 during the delta wave of COVID-19 in India. Prospective audits and feedback (PAF) were conducted concurrently during case discussions on all days during this period. A summary of feedback, including empiric antibiotic rationality, de-escalation, etc., was mailed to all the treating physicians every day. Results: 161 out of 183 patients (87.97%) were empirically prescribed antibiotics in COVID ICUs, with an average of three antibiotics per patient. The most commonly prescribed empiric antibiotic was piperacillin-tazobactam, followed by ceftriaxone and colistin. De-escalation was suggested in 45.2% of prescriptions, which were followed in 36.5% but delayed in around 16% of suggestions. The presence of multiple comorbidities with intubation and/or shock was the most common reason for initiating and continuing empirical antibiotics. Around 29.8% of the patients on antibiotics developed MDR infections, and Acinetobacter baumannii was the most common organism isolated, with an average length of stay of 20 (19.6 days). Conclusion: Antimicrobial stewardship can play an essential role in minimizing the use of unnecessary antimicrobials in COVID-19 patients.
- Open Access
- 6 July 2022
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 13 (3) , 100626
Essential oil nebulization in mild COVID-19(EONCO): Early phase exploratory clinical trial
- 6 July 2022
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 13 (3) , 100626
Open AccessEssential oil nebulization in mild COVID-19(EONCO): Early phase exploratory clinical trial
- Open Access
- 9 February 2021
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 98 (e2) , e84-e85
Some reflections on vaccine research ethics during COVID-19 pandemic
- 9 February 2021
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 98 (e2) , e84-e85
Open AccessSome reflections on vaccine research ethics during COVID-19 pandemic
- 3 June 2020
- Published by SAGE Publications in Lupus
- Vol. 29 (8) , 1002-1003
Efficacy of anifrolumab in systemic lupus erythematosus: a critical analysis of the TULIP trials
- 3 June 2020
- Published by SAGE Publications in Lupus
- Vol. 29 (8) , 1002-1003
Efficacy of anifrolumab in systemic lupus erythematosus: a critical analysis of the TULIP trials